FDA Inspection 1187297 — CCRM New York
The FDA completed an inspection of CCRM New York on October 25, 2022 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 25, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- New York, NY (United States)